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Analysis of encapsidated RNA from the Q strain of CMV (Q-CMV) has indicated the presence of a discreet population of
molecules of approximately 300 nt termed RNA 5 (Peden, K. W. C., and Symons, R. H., Virology 53, 487–492, 1973.). Q-CMV
RNA 5 was isolated and the 5*-end sequence was determined by direct RNA sequencing. This sequence corresponded to
the exact beginning of the imperfectly conserved 3*-terminal region of genomic RNAs 1, 2, and 3. A probe generated from
RNA 3 consisting of the last 130 nt of this region hybridised to RNA 5. Oligonucleotides containing sequences from the 5*-
and 3*-ends of the conserved region were used to generate RNA 5 cDNA clones by RT–PCR on gel-purified RNA 5. Sequencing
of these clones and primer extension analysis of transcripts (derived from the cDNA clones) and purified RNA 5 indicated
that RNA 5 consists of the conserved 3*-terminal region of genomic RNAs 2 and 3. q 1996 Academic Press, Inc.
Cucumber mosaic virus (CMV) is a positive sense, jected to enzymatic sequencing as described in Ding et
single-stranded RNA virus, particles of which contain al. (10). It was also possible to 5*-end label RNA 5 to a
three separate genomic RNAs 1, 2, and 3, and a fourth similar extent without decapping, suggesting that the
subgenomic RNA 4 (1). The RNA 1 and 2 encoded pro- RNA 5 molecules are not capped.
teins are thought to be involved in viral replication (2) The 5*-end RNA sequencing data are presented in Fig.
and the dicistronic RNA 3 encodes the movement protein 1. It is evident from the sequencing gel that the individual
and the coat protein (3), which is expressed via RNA 4 5*-end labeled partially degraded RNA 5 molecules ap-
(4). At the terminus of the 3* untranslated region (UTR) pear as two bands of similar electrophoretic mobility (a
an imperfectly conserved 304- to 307-nt region is present doublet). This is especially evident for the smaller mole-
on RNAs 1–4 (5, 6) which is thought to be involved in cules at the lower end of the gel. As the RNA had been
RNA replication (6, 7). decapped and dephosphorylated prior to end-labeling, it
Several studies have indicated the presence of addi- would seem that the doublet formation is a result of some
tional discreet populations of small RNA molecules kind of, as yet, unidentified 5*-end chemical modification
called 4A and 5 in association with the Q, Kin, and S of the RNA 5 molecules. A similar ‘‘band doubling’’ phe-
strains of CMV (1, 7 – 11). These are distinct from satellite nomena on gels which seemed to be caused by the
RNA (sometimes referred to as CMV-associated RNA 5 oxidation of sulfur residues in modified nucleic acids
[CARNA 5]) which is also found in association with some has been reported previously (14). Clear unambiguous
CMV isolates (12, 13). Q-CMV RNA 4A is a subgenomic sequence (see Fig. 1) could be read from the gel up
RNA derived from the 3*-terminal 682 nt of RNA 2 which to nucleotide 27, after which there was cross-banding,
encodes a 11.3-kDa protein that is expressed in vivo (10). except nucleotide 21 which could be read as either G or
We report here the cloning and characterisation of A. This sequence is identical to the 5*-end of the con-
Q-CMV RNA 5. served region present in the 3* UTR of all CMV genomic
The origin and propagation of Q-CMV and the purifica- RNAs (6). These results indicate that RNA 5 consists of
tion of encapsidated viral RNA has been described else- a population of 5* coterminal RNAs which contain a de-
where (10). To determine the 5*-end sequence, gel-puri- gree of sequence variation. The positions of sequence
fied Q-CMV RNA 5 was 5*-end labeled with [g-32P]ATP variation seen in the RNA sequencing gel (nucleotides
following decapping and dephosphorylation and sub- 21 and 27) are consistent with positions of sequence
variation that exist at the 5*-end of the conserved 3* UTR
of the genomic RNAs (3, 15, 16).1 Current address: CSIRO Division of Plant Industry, GPO Box 1600,
The identity of the 5*-terminal nucleotide could not beACT 2601, Australia.
2 To whom reprint requests should be addressed. ascertained from the sequencing gel and was therefore
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terminal 130 nt of the conserved 3* UTR which is97.7%
conserved between CMV genomic RNAs 1, 2, and 3.
This probe bound to RNA 5, indicating that the RNA 5
molecules contained this sequence and suggesting (in
relation to its size) that RNA 5 consisted of the 3*-end
conserved sequence common to all CMV RNAs. This
result is consistent with that reported in Avila-Rincon et
al. (11) in which partial sequencing of the 3*-terminus of
RNA 5 isolated from the S strain of CMV indicated that
it is highly homologous to the 3* UTR region of the
Q-CMV genomic RNAs.
A 5* primer (consisting of a PstI recognition sequence,
the T7 RNA polymerase promoter sequence, and the 5*
terminal 17 nt of RNA 5), 3* primer (consisting of 17 nt
complementary to the 3*-terminus of all four Q-CMV
RNAs and a MluI recognition sequence), and gel-purified
Q-CMV RNA 5 were used to generate RNA 5 cDNA by
reverse transcription (RT) followed by polymerase chain
reaction (PCR) amplification (10). The full-length PCR
fragments were cloned into pUC18 or pCR1000 (In-
vitrogen) and the cloned inserts were subjected to se-
quence analysis using a Promega Taq Track Sequencing
System or an Applied Biosystems Cycle Sequencing Kit
according to the manufacturer’s instructions.
Twenty-one RNA 5 cDNA clones were sequenced and
could be grouped into three categories according to se-
quence identity: 14 clones were similar to the 3-terminus
of RNA 2 (10, 15), six clones were identical to the 3*-
terminus of RNA 3 (3), and one clone was similar to the
3*-terminus of RNA 1 (16).
To determine whether these three sequence variants
exist in the RNA 5 population primer extension analysis
(17) was performed on purified RNA 5 (Fig. 2). Oligonucle-
FIG. 1. RNA sequencing of the 5* end of Q-CMV RNA 5. Enzymatic
sequencing was as described in Forster and Symons (25). Reaction
mixtures were fractionated on a 20% polyacrylamide gel containing 7
M urea and autoradiographed. A ladder of partially degraded RNA 5
fragments is present in lane N. Lanes G, A / U (2 lanes), and A contain
RNA 5 that has been partially digested with RNAase T1 (cleaves at G
nt), Physarum polycephalum RNAase (cleaves at A and U nt), and
RNAase U2 (cleaves at A nt), respectively. The 5* terminal nucleotide
sequence of RNA 5 is as indicated.
determined by digesting 5*-end 32P-labeled decapped
RNA to completion with P1 nuclease and fractionating
the nucleotide monophosphates on PEI-cellulose in 1 M
FIG. 2. Primer extension analysis of Q-CMV RNA 5. OligonucleotideLiCl followed by identification by autoradiography (data
primers were designed to specifically bind to regions in the conservednot presented). The position of the 5*-terminal G nucleo-
3* terminal region of genomic RNAs 1 (P1), 2 (P2), and 3 (P3) (see text).
tide corresponds exactly to the beginning of the con- These primers were 32P-5*-end labeled and used in primer extension
served region within the 3* UTR of Q-CMV RNAs 1, 2, reactions containing RNA transcribed from cDNA clones of RNA 1-
(lane 1), RNA 2- (lane 2), and RNA 3-like (lane 3) RNA 5 clones andand 3 (3, 15, 16). This conserved sequence is 307 nt in
analysed on a 6% polyacrylamide gel and autoradiographed. Lane 5RNAs 1 and 2 (15, 16) and 304 nt in RNA 3 (3), which
contains primer extension reactions containing the specific primer andcorrelates with the size of RNA 5 as estimated from gel
purified native RNA 5. Lanes A, C, G, and T contain dideoxy sequencing
electrophoretic analysis. Northern analysis of encapsi- reactions of the RNA 2- and RNA 3-like RNA 5 cDNA clones with
dated Q-CMV RNA (data not presented) was conducted the specific primer. Arrows indicate the band that corresponds to the
complement of the 5* terminal nucleotide of RNA 5.using a probe generated from RNA 3 consisting of the 3*-
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FIG. 3. Sequence alignment of the RNA 2- and RNA 3-like RNA 5 clones with the 3* terminal conserved region of genomic RNAs 2 and 3. The
cDNA sequences of the 3* terminal region of RNAs 2 (R2) and 3 (R3) were aligned using the PILEUP and LINEUP programs of the GCG Sequence
Analysis Software package for VAX/VMS computers. Gaps (shown as dots) were introduced into the sequences to facilitate alignment. Positions
of nucleotide substitutions and deletions (dots) between the RNA 2-like RNA 5 cDNA clones (A21 and B69) and genomic RNA 2 are shown. The
RNA 3-like RNA 5 clones were identical to the corresponding sequence in RNA 3. The sequences of the RNA 2 and RNA 3 specific primers are
underlined.
otide primers that specifically bound to the RNA 1- (P1: specific primer no extension product of the correct size
was visible even after long autoradiographic exposure5* CAACCAATAC 3* ), RNA 2- (P2: 5* GATAGTTTAG 3* ),
and RNA 3-like (P3: 5* GTTCCCCGCGCAACAACACG 3* ) times. Trace amounts of a much smaller extension prod-
uct of unknown origin was evident in this reaction. TheseRNA 5 molecules (see Fig. 3) were synthesised and
tested for specificity on RNA that had been transcribed results indicate that RNA 5 consists of two sequence
variants derived from genomic RNAs 2 and 3. The RNAin vitro (17) from cDNA clones of RNA 5 (Fig. 2). Complete
specificity was shown by all three primers on the control 1-like RNA 5 cDNA clone that was generated by RT–PCR
was most likely synthesised from RNA 1 degradationtranscripts. Electrophoretic analysis of primer extension
reactions containing purified RNA 5 and the RNA 2 and products that are known to be copurified with RNA 5 (9).
Of the 21 RNA 5 cDNA clones, 5 (2 each of the RNA3 specific primers showed the presence of bands of the
correct expected size (67 nt and 99 nt for RNA 2- and 2- and RNA 3-like clones and 1 RNA 1-like clone) were
completely sequenced on both strands. In Fig. 3 the com-RNA 3-like RNA 5, respectively) and corresponded to the
correct position on the sequence ladder (see Fig. 2). plete sequences of the RNA 2- and RNA 3-like RNA 5
clones are presented with the corresponding regions ofThe extension products produced from purified RNA 5
appeared to be slightly larger than those produced from genomic RNA 2 (as revised in 10) and RNA 3 (3). Both
RNA 3-like RNA 5 clones were identical in sequence tothe RNA transcripts. This may be related to the doublets
seen in the 5*-end RNA sequencing (see Fig. 1) and the RNA 3. The two RNA 2-like RNA 5 clones show a small
amount of variation to the revised RNA 2 sequence.possibility of some type of 5*-end chemical modification
of RNA 5. A larger extension product can be faintly seen Clone A21 has a T (instead of A) at nucleotide 193 and
a T (instead of a C) at nucleotide 283 of the alignedin the track containing the RNA 2 specific primer and
purified RNA 5 which is due to a cryptic binding site for sequences. The substitution at nucleotide 283 occurs in
the loop of stem B of the proposed tRNA structure (18)this primer in a region 3* of the primer binding region
shown in Fig. 3. In the reaction containing the RNA 1 that is formed by the 3*-terminal 133 nt and is also pres-
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ent in one of the Q-CMV RNA 4A clones (10). The substi- served region present on all CMV RNAs. The tRNA-like
structure within this region is, by analogy with BMV, in-tution at nucleotide 193 occurs in a single-stranded re-
volved in viral replication (6 and references therein). RNAgion of the tRNA structure. Clone B69 has a deletion at
5 could play a role in replication and/or virion assemblynucleotide 184 of the aligned sequences which occurs
as has been suggested previously for CMV RNA 5 (9)in the first base pair position of stem B of the tRNA
and 3*-terminal specific ribonuclease degradation prod-structure and hence may increase the size of the central
ucts of BMV (23). The fact that RNA 5 is encapsidatedloop. Clone B69 also has a substitution of G instead of
suggests that this region is also involved in RNA encapsi-T at nucleotide 292 of the aligned sequences which is
dation. Recent data obtained in our laboratory demon-in a single-stranded region of the proposed tRNA struc-
strate that RNAs 4A and 5 are also present in other CMVture. The overall distribution of conserved and variable
strains from both subgroups I and II (C. L. Blanchard andregions between RNA 2 and 3 in the conserved 3* region
B. J. Anderson, unpublished data).(see Fig. 3) reflects that previously reported (5).
It is possible that RNA 5 is a population of subgenomic
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